30-Day FRN 0920-0641 published

Federal Register / Vol. 71, No. 240 / Thursday, December 14, 2006 / Notices
Evaluation of Selenium in Elk in the
Southeast Idaho Phosphate Resource
Area
Illinois
Belvidere Municipal Landfill #1
Bohn Heat Transfer Facility
Dixie Auto Salvage
Lincoln Limited Landfill
Smith-Douglass
Iowa
Iowa City Former Manufactured Gas
Plant Site
Tails A Waggin’ Pet Resort—Arsenic
Soil Contamination

Louisiana
Bayou Sorrel—Post-Hurricane
Groundwater Sampling Evaluation
Combustion, Inc.—Post-Hurricane
Groundwater Sampling Evaluation
Devil’s Swamp Lake—A Review of Fish
Data
Hurricane Response Sampling
Assessment for D.L. Mud, Inc.
Hurricane Response Sampling
Assessment for Gulf Coast Vacuum
Services
Hurricane Response Sampling
Assessment for PAB Oil & Chemical
Service, Inc.
Hurricane Response Sampling
Assessment for the Agriculture Street
Landfill
Hurricane Response Sampling
Assessment for the Southern
Shipbuilding Corporation
Petro Processors of Louisiana, Inc.—
Post-Hurricane Groundwater
Sampling Evaluation
Maine
Contaminant Accumulation Potential
in Plants and Animals Used by the
Aroostook Band of Micmac Indians at
the Former Loring Air Force Base
Holtrachem Manufacturing Company
Massachusetts
Environmental Data Review for
Witchcraft Heights Elementary School
and Nearby Properties
Former Zonolite Facility—Wemelco
Way

rwilkins on PROD1PC63 with NOTICES

Michigan
I–75/Caniff Area (Hamtramck) Lead
Contamination (a/k/a ‘‘Grand Haven’’
Area (Hamtramck) Lead
Contamination)
Little Black Creek Sediments
Little Black Creek Sediments—
Floodplain Soil Sampling Results
Petersburg Mercury Site

17:54 Dec 13, 2006

Jkt 211000

Texas

Former Park Rapids Dump
Off-Site Soils: CMC Heartland Partners
Lite Yard Site
St. Louis River Sediments: U.S. Steel
Site—Dioxin and Polycyclic Aromatic
Hydrocarbon Chemical Signatures
(Fingerprints) in Sediments
St. Louis River Sediments: U.S. Steel
Site—Technical Review of
Discrepancies in 2002 Lacer Induced
Fluorescence Data, and 2003 and 2004
Analytical Data

Cox Road Dump Site—Barium Health
Concern
Tenaha Wood Treating
Tronox LLC, Texarkana Facility
Washington

Yerington Anaconda Mine Site (a/k/a
Anaconda Mine)

BSB Diversified/Hexcel Corporation—
Evaluation of Ground Water
Contamination
DNR Triangle Gravel Pit
Gilbert Elementary School—Evaluation
of Soil Contamination
Holmes Harbor
Lincoln Elementary School—Evaluation
of Soil Contamination
Manson Elementary School—Evaluation
of Soil Contamination
Naches Valley Intermediate School—
Evaluation of Soil Contamination
Robertson Elementary School—
Evaluation of Soil Contamination
Washington Elementary School—
Evaluation of Soil Contamination

New Hampshire

Wisconsin

Bear Brook Villa
Cancer Incidence: Residents of
Claremont, Sullivan County, New
Hampshire (Wheelabrator-Claremont
Site)

Badger Army Ammunition Plant—
Dinitrotoluene in Private Wells
Econocare Cleaners Vapor Intrusion
Investigation
Redi-Quik Dry Cleaners—Vapor
Intrusion in a Private Residence

Brewer Brothers Petroleum Bulk Plant
Former Cardwell Memorial Hospital
Former Zonolite Company/W.R. Grace
Facility—St. Louis
Sherrill Mini Mart/Health Clinic

Martin County Coal Slurry Release
Rubbertown Industrial Area

VerDate Aug<31>2005

Minnesota

Missouri

Kentucky

75255

Nevada

New Jersey
Adrow Chemical Company Site
Kiddie Kollege—Mercury Exposure
Investigation
Matteo & Sons (a/k/a Matteo Iron and
Metal Site)
New York
Mariners Marsh Park—Area of Concern
North Carolina
Payne Road Solvents
Sigmon’s Septic Tank Service—
Evaluation of Surface Water Data
Ohio

Dated: December 8, 2006.
Kenneth Rose,
Acting Director, Office of Policy, Planning,
and Evaluation, National Center for
Environmental Health/Agency for Toxic
Substances and Disease Registry.
[FR Doc. E6–21263 Filed 12–13–06; 8:45 am]
BILLING CODE 4163–70–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention

Fair Oak Park

[30 Day–07–0641]

Oregon

Proposed Data Collections Submitted
for Public Comment and
Recommendations

North Morrow and Northwest Umatilla
Perchlorate Area
Salem-Keizer School District—3M
Flooring
Pennsylvania
Former W.R. Grace/Zonolite Co.
Facility—Investigation of Nearby Play
Area
Waymart Spill Site
Tennessee
Clover Creek Workers (a/k/a Velsicol
Chemical Corp.)
Cypress Creek Sub-Area III
Glover Site (a/k/a Tennessee Products)
Skyline Drive Dump

PO 00000

Frm 00029

Fmt 4703

Sfmt 4703

The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at 404–639–4604 or send a
e-mail to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.

E:\FR\FM\14DEN1.SGM

14DEN1

75256

Federal Register / Vol. 71, No. 240 / Thursday, December 14, 2006 / Notices

Background and Brief Description
Descriptive Epidemiology of Missed
or Delayed Diagnoses for Conditions
Detected by Newborn Screening—(OMB
No. 0920–0641)—Revision—National
Center for Environmental Health
(NCEH), Centers for Disease Control and
Prevention (CDC). Every state in the
United States and Washington, DC, has
a public health program to test newborn
babies for congenital metabolic and
other disorders through laboratory
testing of dried blood spots. These
programs screen for between four and
36 different conditions including
phenylketonuria (PKU) and congenital
hypothroidism, with testing performed
in both state laboratories and private
laboratories contracted by state health
departments. The screening process or
system is broader than the state public
health newborn screening program,
which is composed only of the
laboratory and follow-up personnel.
Most children born with metabolic

disease are identified in a timely
manner and within the parameters
defined by the newborn screening
system of each state. These children are
referred for diagnosis and treatment.
However, some cases are not detected at
all or the detection comes too late to
prevent harm. These ‘‘missed cases’’
often result in severe morbidity such as
mental retardation or death.
In this project, we will continue to
collect information about missed or
delayed diagnoses in order to update
and expand a previous epidemiological
study of missed cases of two disorders
published in 1986. We will assess the
number of cases of each disorder
missed, and the potential reasons for the
miss and legal outcomes. Data will be
collected by asking state public health
laboratory directors, newborn screening
laboratory managers, follow-up
coordinators, specialists at metabolic
clinics, and parent groups with an
interest in newborn screening for

information regarding missed cases. An
estimated 135 remaining respondents
will participate in our study by
completing one or two short
questionnaires that ask for information
regarding the details of any missed or
delayed cases of which they are aware.
The survey will highlight procedures
and actions taken by states and other
participants in newborn screening
systems to identify causes of missed
cases and to modify policies and
procedures to prevent or minimize
recurrences. The information gleaned
from this study may be used to help
craft changes in the screening protocols
that will make the process more
organized and efficient and less likely to
fail an affected child.
Respondent burden is approximately
3 minutes for the State Form and 10
minutes for the Case Report Form. There
are no costs to the respondents other
than their time. The total estimated
annual burden hours are 28.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average
burden
(hours)
per response

Total
burden
(hours)

Form name

Director, State Newborn Screening
Laboratory.

State Form ..........................................

25

1

3/60

1.3

Case
State
Case
State
Case
Case
Case

25
25
25
60
60
5
20

1
1
1
1
1
1
1

10/60
3/60
10/60
3/60
10/60
10/60
10/60

4.2
1.3
4.2
3
10
0.8
3.3

Follow-up State Coordinator ...............
Metabolic Clinic Employee .................
Parent Advocate .................................
Parent .................................................

Dated: December 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 06–9723 Filed 12–13–06; 8:45 am]
BILLING CODE 4163–18–M

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-07–05AJ]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
rwilkins on PROD1PC63 with NOTICES

Number of
respondents

Respondents

In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic

VerDate Aug<31>2005

17:54 Dec 13, 2006

Jkt 211000

Report Form ..............................
Form ..........................................
Report Form ..............................
Form ..........................................
Report Form ..............................
Report Form ..............................
Report Form ..............................

summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should

PO 00000

Frm 00030

Fmt 4703

Sfmt 4703

be received within 60 days of this
notice.
Proposed Project
National Surveillance for Severe
Adverse Events Associated with
Treatment of Latent Tuberculosis
Infection—New—Division of
Tuberculosis Elimination (DTBE),
National Center for HIV, STD, and TB
Prevention (NCHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
As part of the national TB elimination
strategy, the American Thoracic Society
and CDC have published
recommendations for targeted testing for
TB and treatment for latent TB infection
(LTBI). However, between October 2000
and September 2004, the CDC received
reports of 50 patients with severe
adverse events associated with the use
of the two or three-month regimen of
rifampin and pyrazinamide (RZ) for the
treatment of LTBI; 12 (24%) patients

E:\FR\FM\14DEN1.SGM

14DEN1